VP EMEA Commercial Finance at Danaher Corporation

Schiphol-Rijk, North Holland, Netherlands

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Diagnostics, Medical DevicesIndustries

Requirements

BA or advanced degree in Accounting, CPA certification or equivalent skilled in US GAAP
20 years relevant experience in medium to large scale organization ideally in med tech/life sciences industry
Commercial Finance experience, appropriately engaging personality with executive presence so that you are sought out as a solution provider and problem solver
Experience working with peers and leaders in non-accounting and financial functions (Sales, Marketing, R&D, Manufacturing, Logistics)
Demonstrated track record of creating and managing lean teams
Demonstrated experience in driving improved results via excellent forecasting of a business, experience in counter-measuring shortfalls and recommending and actioning plan to remedy
Demonstrated experience in Europe and Africa within similar regulated industry
Detailed orientation, passion and curiosity to dive into problem areas

Responsibilities

Be the lead business/finance partner to the commercial leader(s) of the EMEA Commercial and EMEA HBDC businesses
Own the EMEA HBDC and Commercial forecast by month and by product line working with the VP Commercial/General Manager EMEA and other business owners to formulate the forecast for both revenue and margin (emphasis on profitability in line with overall Cepheid average and core sales growth on YoY basis)
Provide high integrity advice and expertise for complex commercial transactions ensuring growth and profitability while maintaining compliance to laws and regulations
Lead efforts for financial justification of go-direct strategies as appropriate depending on needs of business and competitive demands associated with local competitive situations
Maintain contact with OPCO Finance leadership so that investment needs are openly communicated and validated within the constraints of Cepheid’s global investment strategy (HIV investment priorities will be a large driver for growth given TB maturity)
Partner with OPCO Finance and business leaders to drive improved results in working capital (Accounts Receivables, Inventory and Accounts Payable)
Own responsible Accounts Receivable and Inventory levels for the business that balances delivery vs carrying cost particularly given product shelf-life issues
Drive organizational improvements to develop the best team possible and work with staff to ensure that adequate development plans are in place so that we create and grow a bench of high integrity financial analysts and business partners for EMEA growth and profitability

Skills

Financial Forecasting

Financial Reporting

Strategic Finance

Revenue Forecasting

Margin Analysis

Profitability Analysis

Commercial Transactions

Business Partnering

Product Line Management

YoY Growth Analysis

Danaher Corporation

Water quality, diagnostics, and identification solutions

About Danaher Corporation

Danaher Corporation operates in key markets such as water quality, product identification, and diagnostics. The company provides precision instruments and advanced purification technologies for analyzing and managing water, ensuring its safety in various environments. In product identification, Danaher specializes in laser marking, coding, and packaging solutions that help maintain product freshness and accurate labeling throughout the supply chain. In the diagnostics sector, Danaher offers tools and software that enhance diagnostic confidence, enabling healthcare providers to deliver effective care. What sets Danaher apart from competitors is its unique Danaher Business System, which focuses on continuous improvement and empowers employees to drive change. The company's goal is to consistently deliver high-performance products and solutions while maintaining leadership in its markets.

Washington, District of ColumbiaHeadquarters

1969Year Founded

IPOCompany Stage

Industrial & Manufacturing, Healthcare, Consumer GoodsIndustries

10,001+Employees

Risks

Increased competition from Roche and Abbott in AI-driven diagnostics.

Potential regulatory challenges in the EU for water quality sector.

Supply chain vulnerabilities affecting precision instruments sourcing.

Differentiation

Danaher's Danaher Business System drives continuous improvement and superior financial performance.

The acquisition of Cytiva enhances Danaher's capabilities in the biopharmaceutical sector.

Danaher's advanced purification technologies meet increasing demands for sustainable water management.

Upsides

Danaher's investment in AI-driven healthcare solutions boosts its diagnostics capabilities.

Cytiva acquisition expands Danaher's market share in the biopharmaceutical sector.

Point-of-care testing demand drives growth for Danaher's diagnostic tools and software.

Land your dream remote job 3x faster with AI

Try Jobo Free